אומפרה 10

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

OMEPRAZOLE 10 MG

MAH:

RAFA LABORATORIES LTD

ATC_code:

A02BC01

pharmaceutical_form:

CAPSULES

administration_route:

PER OS

manufactured_by:

LABORATORIOS LICONSA S.A., SPAIN

therapeutic_group:

OMEPRAZOLE

therapeutic_indication:

Acute duodenal ulcer, Acute gastric ulcer, Helicobacter pylori associated peptic ulcer disease in combination with antibiotics. Reflux esophagitis: Treatment long-term management, Maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. Treatment of severe reflux esophagitis in children from one year of age and older. Maintenance treatment for the prevention of relapse in patients with poorly reponsive peptic ulcer. Zollinger-Ellison Syndrome. Treatment and prevention of NSAID-associated duodenal and gastric ulcer or erosions in high risk patients.

authorization_date:

2012-06-01